CureMetrix
Rick Valencia is a strategic advisor at CureMetrix. Rick has also served as a member of the board of directors and chairman of nominating & governance committee at Tandem Diabetes Care, and as analytics ventures and CareAlign. During their Tandem tenure, they assisted with a leadership succession that went flawlessly, helped to evolve the company’s mindset from a medical device manufacturer to an insulin therapy management provider, and as Chairman of the Nominating and Governance committee, added three new board members and oversaw a transformation of the board of directors to a more diverse group of professionals that added significant value and aligned well with the needs of the business. Rick would have remained as a Tandem Diabetes board member, but in mutual agreement with the CEO and board, they resigned when they took the helm of WaveForm Diabetes, which was not competitive to Tandem, but could have created conflicts with some of Tandem's partners.
Rick Valencia has a Bachelor of Business Administration from California State University, Northridge in the field of finance.
This person is not in the org chart
CureMetrix
CureMetrix is committed to the advancement of technology that improves disease detection and cancer survival rates worldwide. CureMetrix' AI-based products and research are focused on leveraging artificial intelligence and deep learning to develop the next generation of medical image analysis technology that radiologists and patients can confidently rely on.